Coronavírus Página 9

THE LANCET - Scientific consensus on the COVID-19 pandemic: we need to act now

The LancetSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 35 million people globally, with more than 1 million deaths recorded by WHO as of Oct 12, 2020. As a second wave of COVID-19 affects Europe,...

THE LANCET - Genomic evidence for reinfection with SARS-CoV-2: a case study

The LancetThe degree of protective immunity conferred by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently unknown. As such, the possibility of reinfection with SARS-CoV-2 is not well understood. We describe...

NEJM - Remdesivir for the Treatment of Covid-19 — Final Report

The New England Journal of MedicineAlthough several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.

DGS - Diagnóstico COVID-19 - Testes de pesquisa de antigénio

Orientação da Direção-Geral da SaúdeOs testes de pesquisa de antigénio desenvolvidos para o diagnóstico do SARS-CoV-2, são testes maioritariamente imunocromatográficos que detetam proteínas específicas do vírus SARS-CoV-2, produzidas pelo vírus...

DGS - COVID-19: Abordagem do Doente com Suspeita ou Confirmação de COVID-19

Direção-Geral da Saúde

Desde o reconhecimento da doença pelo novo coronavírus (COVID-19) como Pandemia pela Organização Mundial de Saúde que têm sido adotadas várias medidas para prevenir e conter a transmissão do vírus SARS-CoV-2.

BMJ - In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

British Medical Journal

To estimate the incidence, risk factors, and outcomes associated with in-hospital cardiac arrest and cardiopulmonary resuscitation in critically ill adults with coronavirus disease 2019 (covid-19).

JAMA - Risk of COVID-19 During Air Travel

JAMA NETWORKThe risk of contracting coronavirus disease 2019 (COVID-19) during air travel is lower than from an office building, classroom, supermarket, or commuter train.he risk of contracting coronavirus disease 2019 (COVID-19) during air...

AMP - COVID-19 and Seasonal Flu During the Autumn-Winter of 2020/2021 and the Challenges Lying Ahead for Hospitals

Acta Médica PortuguesaThe possibility of a second wave of the COVID-19 pandemic coexisting with a simultaneous epidemic of influenza and the co-circulation of other seasonal respiratory viruses sets the stage for a perfect storm. Preparing for...

ECDC - Infection prevention and control and preparedness for COVID-19 in healthcare settings - fifth update

European Centre for Disease Prevention and ControlHealthcare facilities, including long-term care facilities (LTCFs), should apply several types of measures to minimise the risk of transmission of COVID-19. The mainstays of infection...

The Lancet - Clinical features of COVID-19 mortality: development and validation of a clinical prediction model

The LancetPredicting mortality among patients with COVID-19 who present with a spectrum of complications is very difficult, hindering the prognostication and management of the disease. We aimed to develop an accurate prediction model of COVID-19...

JAMA - Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

JAMA NETWORKWhat are the risk factors associated with hospitalization, mechanical ventilation, and death among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection?

JAMA - Association of SARS-CoV-2 Test Status and Pregnancy Outcomes

JAMA NETWORKAssociations of coronavirus disease 2019 (COVID-19) and pregnancy outcomes remain unclear because most studies are case reports or case series without contemporary comparators. We compared pregnant persons in labor who were infected...

ECDC - Guidelines for the implementation of non-pharmaceutical interventions against COVID-19

European Centre for Disease Prevention and ControlNon-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARSCoV-2 transmission in the community. As long as there is no effective and safe vaccine to...

The Lancet - Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

The LancetHydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to examine whether patients with rheumatological conditions receiving...

ECDC - Threat Assessment Brief: Reinfection with SARS-CoV-2: considerations for public health response

European Centre for Disease Prevention and ControlCases with suspected or possible reinfection with SARS-CoV-2 have been recently reported in different countries. In many of these cases, it is uncertain if the individual’s Polymerase Chain...